Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Unaudited financial result for the Third Quarter ended on 31 December, 2025 along with the Auditor''s Limited Review Report.